MT EVEREST

[FUZO]

TweetIS FORMING UNDER MY LEFT NIPPLE NOLVA ISNT DOING SHIT.FUNNY THING IS THE LUMP I HAD UNDER MY RIGHT ONE DIDNT MOVE AND THAT WAS THE BIGGER ONE.ITS JUST THE LEFT ONE THAT BALLOONED.WHAT SHOULD I GET TO BRING THE LUMP DOWN SOME WHAT

[SMILEY FACE]

Tweetwhat are u taking (supp)..cut down the dosage.....
increase the nolv to 40 mg a day and ur best bet is arimidex...not the liquid form...the real tb from teh doct....

[MaxSwells]

Tweetwhat are you taking bro? I get bad gyno from Tren & Gh, you can easily get rid of with Cabasser (expensive as shit)...from personal experience, when I had a lump the size of texas under my right nip, I took Femara 1tab ED (2.5mg)...this is the kick ass Arimidex which was well worth the money cause the shit disappeared in a week...I do not think that Nolva works as good as Arim (atleast for me) to dissipate lumps...try Femara if you can get it, you will not b disappointed...

[HungarianBeast]

TweetFemara (letrozole) is different that Arimidex (anastrozole) and Nolvadex (Tamoxifen). Femara's effects are closer to Nolvadex that Arimidex.

[MaxSwells]

TweetWhat would you rather use?

[MaxSwells]

TweetFrom what I've always gathered, Femara was closer to Adex then Nolva...

Femara is 10-30x more effective than Arimidex in it's ability to pass thru the cell membrane of lipid (fat) cells and inhibit the activity of aromatase -- in other words, Femara is far superior in lowering estrogen levels in fat cells. This has two benefits for BBs; (1) Estrogen 'attracts' water, so less water retention (2) an average male BB is around 10%BF, that's a lot of lipid cells with aromatase inside them, so a substantial percentage of aromatase is left untouched by Arimidex due to it's poor ability to enter lipid cellsArimidex is approximately 80% effective at inhibiting aromatase, Femara is around 95-97%, Aromasin is 98-99%

notes:
1. J Clin Endocrinol Metab 2000 Jul;85(7):2370-7
2. J Steroid Biochem Mol Biol 1997 Nov-Dec;63(4-6):261-7

[HungarianBeast]

Tweethttps://www.pslgroup.com/dg/200B2E.htm

ESPE: Tamoxifen, Raloxifene Prove Effective In Pre-Pubertal Gynecomastia

By Cameron Johnston
Special to DG News

MONTREAL, QC -- July 12, 2001 -- Doctors in Canada, have determined that both tamoxifen and raloxifene can be used to treat pre-pubertal gynecomastia.

This condition, an excessive development of male breasts, occurs in up to 65 percent of young boys and may be deemed clinically significant in 10-15 percent.

While the condition resolves spontaneously in approximately 90 percent of cases over a three year period, the psychological and emotional impact in the meantime can be devastating for these young patients.

The investigators, headed by Dr. Sarah Muirhead, an associate professor of medicine at the University of Ottawa and staff endocrinologist at Children's Hospital of Eastern Ontario (CHEO), presented these findings yesterday (July 11th, 2001) at the 6th joint meeting of the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology (ESPE), in collaboration with the Australasian Paediatric Endocrine Group, the Japanese Society for Pediatric Endocrinology, and the Latin American Society for Paediatric Endocrinology held in Montreal, Quebec, Canada.

The tamoxifen/raloxifene breakthrough is significant because surgery used to be the only management option. Previous attempts to manage the condition medically by altering the testosterone/estrogen ratio have only been partially effective and have included such drugs as danazol (normally used to treat endometriosis), aromatase inhibitors, and dihydro-testosterone.

Tamoxifen is a competitive inhibitor of estrogen binding in the breast, whereas raloxifene is a selective estrogen receptor modulator, the investigators explained.

In the study, 14 subjects received tamoxifen 10-20 mg/day for three to six months, while nine subjects received 60 mg/day of raloxifene for three to six months. A group of 13 received no medications and were used as a control group.

The mean age of these boys was 14 years, and all were of normal body mass index. Those who received tamoxifen had had the condition for a mean period of 18.9 months, while those randomized to raloxifene had the condition for an average of 37.2 months.

Both of these estrogen receptor blockers were effective in treating gynecomastia, although the response was greater for raloxifene. In the tamoxifen group, the mean nodule size was 4.6 cm before treatment and 2.1 cm post-treatment, for a reduction in size of 56 percent.

In the raloxifene group, pre-treatment nodule size was 4.9 cm and post-treatment size was 1.6 cm -- a reduction in size of 73 percent. It was not stated over what period of time these changes occurred.

The investigators report that overall, 91 percent of the subjects showed a positive response. These results were especially encouraging given that the subjects had had the condition for extended periods of time, and given that the breast nodules were large. It was also encouraging that no side effects were seen in either group of patients, including to liver function.

Despite the safety of the drug and the seemingly impressive results seen here, Dr. Muirhead and her group caution that, due to the lack of follow-up in untreated patients, it is not clear whether treatment was more effective than observation alone. To resolve that question, a larger, randomized, placebo-controlled trial using raloxifene has been planned, she said.

[MaxSwells]

TweetLOL, so which one would you rather use bro?:-)

[HungarianBeast]

Tweet

LOL, so which one would you rather use bro?:-)

ummm... Iced tea with lemon... sooooooo refreshing.

[MaxSwells]

TweetI'm with ya on that one

[SMILEY FACE]

Tweetdamn both of u...i have tried arimixed and that was very good..... might as well, take nolv and arimidex same tine fuzzy nuts

[president_fad]

Tweet

what are u taking (supp)..cut down the dosage.....
increase the nolv to 40 mg a day and ur best bet is arimidex...not the liquid form...the real tb from teh doct....

whuts the diff between arimidex, in the pill and liquid.

[MaxSwells]

Tweet^^^ probably not much difference in strength or potency, but I'd still rather get human grade meds...

[SMILEY FACE]

Tweet

whuts the diff between arimidex, in the pill and liquid.

the liquid from the reasearch company not as good as teh real tbs from teh doct..... teh difference is the strenght...
don't remember where i saw a post that teh liquid form not as strong as teh real tbs...
and that includes nold and clomid as well....